One of the proposed models of the increased resistance of CLL cells inside lymph nodes is the increased expression of MCL1, BCL-XL, and BCL2A1, being a consequence of augmented BCR, CD40, and TLR9 signaling [67,68,69,70]. This evidence concerns the gene BCL2L1 and B-cell chronic lymphocytic leukemia.